These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 21697455)
1. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503 [TBL] [Abstract][Full Text] [Related]
3. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. Tanaka K; Albin MJ; Yuan X; Yamaura K; Habicht A; Murayama T; Grimm M; Waaga AM; Ueno T; Padera RF; Yagita H; Azuma M; Shin T; Blazar BR; Rothstein DM; Sayegh MH; Najafian N J Immunol; 2007 Oct; 179(8):5204-10. PubMed ID: 17911605 [TBL] [Abstract][Full Text] [Related]
4. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277 [TBL] [Abstract][Full Text] [Related]
5. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874 [TBL] [Abstract][Full Text] [Related]
6. CD28-independent costimulation of T cells in alloimmune responses. Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727 [TBL] [Abstract][Full Text] [Related]
15. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773 [TBL] [Abstract][Full Text] [Related]
16. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. D'Addio F; Ueno T; Clarkson M; Zhu B; Vergani A; Freeman GJ; Sayegh MH; Ansari MJ; Fiorina P; Habicht A PLoS One; 2013; 8(4):e60391. PubMed ID: 23593209 [TBL] [Abstract][Full Text] [Related]
17. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses. Yamaura K; Watanabe T; Boenisch O; Yeung M; Yang S; Magee CN; Padera R; Datta S; Schatton T; Kamimura Y; Azuma M; Najafian N Am J Transplant; 2010 Oct; 10(10):2355-62. PubMed ID: 21143433 [TBL] [Abstract][Full Text] [Related]
18. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the B7 costimulatory pathway in allograft rejection. Pearson TC; Alexander DZ; Corbascio M; Hendrix R; Ritchie SC; Linsley PS; Faherty D; Larsen CP Transplantation; 1997 May; 63(10):1463-9. PubMed ID: 9175811 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]